As of 2025-05-23, the Fair Value of Zynerba Pharmaceuticals Inc (ZYNE) is -3.48 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.30 USD, the upside of Zynerba Pharmaceuticals Inc is -367.98%.
With the market price of 1.30 USD and our fair value calculation, Zynerba Pharmaceuticals Inc (ZYNE) is not a good investment. Investing in ZYNE stocks now will result in a potential loss of 367.98%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -39.91 | -32.94 | -51.34 | -37.31 | -35.04 | -39.31 |
| YoY growth | -24.68% | 17.46% | -55.86% | 27.33% | 6.09% | -5.93% |
| Market Cap (mil) | 70.12 |
| P/E | |
| Forward P/E |
| EPS | -0.70 |
| Avg earnings growth rate | -5.93% |
| TTM earnings | -37.58 |